Rapamycin has captured the imagination of medical researchers for some time. It has wider areas of application and can be concluded as a drug that has numerous properties and benefits. However, when it was initially isolated in 1972, medical science thought that it is an anti-fungal agent. But in the later years, researches have proved that it has some deeper applications than initially thought and stopped using it as an anti-fungal drug. A majority of its applications are identified by the prominent researcher, Mikhail Blagosklonny. He is known for conducting researches focused on Rapamycin and identified its properties of anti-aging, immunosuppressant, cancer treatment, and more. Follow Mikhail on Google Scholar.
He says that the immunosuppressant quality of the drug is useful in organ transplant surgeries where Rapamycin avoids the rejection tendency of the human body for external organs. Also, the drug shows the least level of toxicity to various organs, especially in kidneys. The hemolytic-uremic syndrome is a deadly and rare condition kidney failure combined with low platelet count and anemia. While making kidney transplant in those patients, Rapamycin is used to avoid the chances of the new organ getting the same disease. It is also used in coronary stents to coat it with the drug to avoid possibilities of re-stenosis.
Though it is at the primitive stages of research, Mikhail Blagosklonny predicts that proper dosage of Rapamycin can ensure controlling the growth of cancer. It has the capacity to invoke the immune response of the human body and creates a regression towards cancer. Tuberous Sclerosis Complex, which is generally known TSC, is another disease that can receive significant improvement with Rapamycin. Anti-aging properties and longevity are two important areas of application for Rapamycin, per Mikhail Blagosklonny. He conducted many tests in animals like mice and found excellent results in improving the healthier lifespan. The recent years saw a lot of tests and researches in the area due to overall health effects of Rapamycin.
Mikhail Blagosklonny has long years of exposure in various roles including research guide, professor, journal reviewer, philanthropist, and more. He is motivated by the concept of creating best treatment options to patients around the world that are available to everyone regardless of their financial conditions. Mikhail Blagosklonny has done extensive research in cancer and aging – the most important subjects of modern healthcare. While coming to cancer, Blagosklonny is working on a novel methodology based on precision medication, which targets only the affected cells, not the healthy cells. It is considered as an innovative concept in cancer treatment and recovery process.
It was a long-term goal of oncologists to develop a method of treatment that ensures most effective treatment for cancer. The researches of Blagosklonny is expected to produce fruitful results in the area and take to the next level of treatment. He is hopeful that at least he can pave ways for the treatment procedure as other researchers can continue from where he stops. Blagosklonny shares a vision of cancer treatment that is no longer a costly treatment but accessible to everyone who is suffering from the deadly disease. View Mikhail’s profile in LinkedIn.